SUMMARYSpecific polyclonal antisera to human interferon-~l (HulFN-~I), human interferon-~2 (HulFN-~2) and human lymphoblastoid interferon (HulFN-ctLy Namalwa) have been raised in rabbits and sheep. The antisera raised against HulFN-~I and HulFN-~2 strongly neutralized the antiviral activity of their homologous IFN-~ subtypes, but were less active against the heterologous IFN-~ subtypes and preparations containing mixtures of IFN-~ subtypes, e.g. human leukocyte interferon (HulFN-aLe). Antisera raised against HulFN-aLy Namalwa strongly neutralized the antiviral activity of all IFN-~-containing preparations and showed weak cross-reactivity with human interferon-fl (HulFN-fl). Neither anti-HulFN-~l nor anti-HulFN-~2 could be demonstrated to neutralize the antiviral activity of HulFN-fl. A number of monoclonal antibodies to HulFN-a2 have been prepared and these were found to neutralize HulFN-~2 antiviral activity to varying degrees, but not to neutralize the heterologous subtype HulFN-~ 1, preparations containing mixtures of IFN-~ subtypes or HulFN-fl.
An immunoprecipitation technique, which uses radiolabeled human gamma interferon (HuIFN-gamma) and a sheep anti-mouse F(ab')2 serum, is described for the rapid detection of mouse monoclonal antibodies to IFN-gamma in hybridoma culture supernatants. This technique which can be performed in 4 h detects both neutralizing and nonneutralizing antibodies to IFN-gamma. Certain monoclonal antibodies prepared against natural (glycosylated) IFN-gamma which neutralized the antiviral activity of natural IFN-gamma bound strongly to rDNA (unglycosylated) IFN-gamma derived from E. coli, but failed to neutralize its antiviral activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.